ACR GUIDELINES Bundle (free trial)

Arteritis ACR 2021

American College of Rheumatology GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1449144

Contents of this Issue

Navigation

Page 3 of 13

4 Key Points and Definitions Table 3. Treatments and Interventions Used in the Recommendations and Ungraded Position Statements for GCA and TAK Term Definition Pulse intravenous glucocorticoids Methylprednisolone: • Adults: 500–1000 mg/day given intravenously for 3–5 days, or equivalent • Children: 30 mg/kg/day (maximum 1000 mg/day) given intravenously for 3–5 days, or equivalent High dose oral glucocorticoids Prednisone: • 1 mg/kg up to 80 mg daily or equivalent Moderate dose oral glucocorticoids Prednisone: • Adults: 0.5 mg/kg/day (generally between 10–40 mg/day) or equivalent • Children: 0.5 mg/kg/day or equivalent Low dose oral glucocorticoids Prednisone: ≤10 mg daily or equivalent Non-glucocorticoid non-biologic immunosuppressive therapy Azathioprine, leflunomide, methotrexate, mycophenolate mofetil, cyclophosphamide Biologics Abatacept, tumor necrosis factor (TNF)-α inhibitors, tocilizumab Surgical intervention Angioplasty, stent placement, vascular bypass, vascular gra

Articles in this issue

Archives of this issue

view archives of ACR GUIDELINES Bundle (free trial) - Arteritis ACR 2021